Clinical trials
Observational Knee Injuries trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
75 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 2 |
| 2012 | 4 |
| 2014 | 4 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 5 |
| 2022 | 11 |
| 2023 | 6 |
| 2024 | 5 |
| 2025 | 9 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 40 |
| Recruiting | 11 |
| Unknown status | 11 |
| Active, not recruiting | 4 |
| Not yet recruiting | 4 |
| Terminated | 2 |
| Enrolling by invitation | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The University of Tennessee, Knoxville | 3 |
| Vanderbilt University Medical Center | 3 |
| Hacettepe University | 2 |
| Istituto Ortopedico Rizzoli | 2 |
| Kırklareli University | 2 |
| Smith & Nephew, Inc. | 2 |
| Stefano Zaffagnini | 2 |
| Technical University of Munich | 2 |
| University of Oulu | 2 |
| Abdirahman Hassan Omar | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Knee Injuries | 75 |
| Anterior Cruciate Ligament Injuries | 20 |
| Osteoarthritis | 9 |
| Osteoarthritis, Knee | 9 |
| Disease | 7 |
| Wounds and Injuries | 7 |
| Ankle Injuries | 4 |
| Athletic Injuries | 4 |
| Hip Injuries | 3 |
| Pain | 3 |
Trials
Showing 1 to 25 of 75. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.